SCHEMBL217356

SCHEMBL217356

CCOC(=O)n1ccnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
TBXAS1 P24557 5/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 2/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
ATM Q13315 1/20 0.38
ABL1 P00519 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL9135732 0.94 KDM4E (0.40) ALDH1A1KDM4EMAPTMEN1MITF
SCHEMBL17517848 0.90 TBXAS1 (0.48) ALDH1A1KDM4EMAPTMEN1MITF
SCHEMBL2899421 0.87 AHR (0.40) ALDH1A1TBXAS1CYP1A2CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL27697276 0.86 SOAT1 (0.44) ALDH1A1KDM4EMAPTMEN1MITF
SCHEMBL12016623 0.86 ALDH1A1 (0.39) ALDH1A1MAPTMEN1KMT2ATBXAS1
SCHEMBL943943 0.84 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2TBXAS1CYP1A2CYP2D6
SCHEMBL2218227 0.83 MAPT (0.46) ALDH1A1KDM4EMAPTMEN1MITF
SCHEMBL1572095 0.83 TBXA2R (0.42) SMN1; SMN2TBXAS1CYP2D6TDP1TSHR
SCHEMBL22125599 0.83 CYP24A1 (0.34) ALDH1A1KDM4EMAPTMEN1MITF
SCHEMBL23634090 0.82 ALDH1A1 (0.37) ALDH1A1MAPTFAAHMGLLTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12194448-B2 Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same THE GEORGE WASHINGTON UNIVERSITY (US) 2025-01-14 US claimed
US-20240150390-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-05-09 US claimed
EP-4286393-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE Daiichi Sankyo Company, Limited (JP) 2023-12-06 EP claimed
CN-116867795-A Novel method for producing antibody-immunostimulant conjugate 第一三共株式会社 2023-10-10 CN claimed
US-20200171474-A1 CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME THE GEORGE WASHINGTON UNIVERSITY 2020-06-04 US claimed
US-10570243-B2 Non-tin catalyst for curing alkoxysilyl-containing polymer MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2020-02-25 US claimed
CN-109160997-B Alkali solubility UV-cured resin, preparation method containing urethano and the ultraviolet light solidification etch-resistant material containing it 广东三求光固材料股份有限公司 2019-11-19 CN claimed
CN-109937225-A For solidifying the non-tin catalyst of the polymer containing alkoxysilyl 莫门蒂夫性能材料股份有限公司 2019-06-25 CN claimed
CN-109160997-A Alkali solubility UV-cured resin, preparation method containing urethano and the ultraviolet light solidification etch-resistant material containing it 佛山市三求光固材料股份有限公司 2019-01-08 CN claimed
CN-107407873-B Photoimageable compositions containing thermal base generators 住友电木株式会社 2018-12-04 CN claimed
US-20090018123-A1 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation SINDKHEDKAR MILIND D 2009-01-15 US claimed
US-20090011124-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes HSIEH BING 2009-01-08 US claimed
EP-1912980-A2 OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION Wockhardt Limited (IN) 2008-04-23 EP claimed
EP-1778778-A2 ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS King Industries, Inc. (US) 2007-05-02 EP claimed
WO-2007023507-A2 OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION WOCKHARDT LIMITED (IN) 2007-03-01 WO claimed
US-20060247341-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes KING INDUSTRIES, INC. 2006-11-02 US claimed
WO-2006022899-A2 ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS KING INDUSTRIES, INC. (US) 2006-03-02 WO claimed
US-20060036007-A1 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2006-02-16 US claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed
EP-0076140-A2 1,3-Disubstituted imidazoles and a process for their production Kissei Pharmaceutical Co. Ltd. (JP) 1983-04-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150390-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE PAICS, COASY, CDS2 ALDH1A1 4101/4885KDM4E 4464/4885MAPT 4562/4885
US-12194448-B2 Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same MLX, LDHA, CA2 ALDH1A1 1229/4885KDM4E 3677/4885MAPT 3209/4885
US-20090018123-A1 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation POLL, POLM, POLRMT ALDH1A1 1847/4885KDM4E 3677/4885MAPT 4657/4885
US-20200171474-A1 CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME MLX, LDHA, CA2 ALDH1A1 1229/4885KDM4E 3677/4885MAPT 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.